MyFinsight
Home
Blog
About
Proceeds from issuance of
common stock, net of...
$10,699,794
(133.12%↑ Y/Y)
Proceeds from issuance of
common stock for...
$4,283,912
Net cash provided by
financing activities
$14,983,706
(225.89%↑ Y/Y)
Effect of foreign
exchange rates on cash and...
$1,492
(-94.51%↓ Y/Y)
Net increase
(decrease) in cash and cash...
$2,972,403
(156.25%↑ Y/Y)
Canceled cashflow
$12,012,795
Depreciation and
amortization
$1,163,847
(19.97%↑ Y/Y)
Impairment of long-lived
assets
$298,555
(35.67%↑ Y/Y)
Inventories
-$216,638
(-52.22%↓ Y/Y)
Stock-based compensation
$195,208
(-18.00%↓ Y/Y)
Non-cash adjustment on
r&d expenditure...
-$124,924
(-190.72%↓ Y/Y)
Inventory write-downs
$62,044
Provision for credit
losses
$9,974
(1726.74%↑ Y/Y)
Proceeds from sale of
assets held for sale
$40,158
Net cash used in
operating activities
-$11,927,222
(-23.25%↓ Y/Y)
Net cash used in
investing activities
-$85,573
(63.09%↑ Y/Y)
Canceled cashflow
$2,071,190
Canceled cashflow
$40,158
Net loss
-$12,468,672
(-17.57%↓ Y/Y)
Purchase of property and
equipment
$125,731
(-45.77%↓ Y/Y)
Accounts payable and
accrued expenses
-$684,743
(-126.57%↓ Y/Y)
Accounts receivable
$253,850
(53.93%↑ Y/Y)
Other current assets
$203,956
(-38.08%↓ Y/Y)
Operating lease
liabilities
-$191,725
(29.38%↑ Y/Y)
Non-cash other operating
activities
$87,933
(177.38%↑ Y/Y)
Research and development
tax incentive...
$72,543
(-65.30%↓ Y/Y)
Long-term employee
benefit liabilities
-$34,990
(-264.23%↓ Y/Y)
Back
Back
Cash Flow
INTELLIGENT BIO SOLUTIONS INC. (INBS)
INTELLIGENT BIO SOLUTIONS INC. (INBS)
source: myfinsight.com